- Home
- AEI vs EDSA Comparison
AEI vs EDSA Comparison
Compare AEI & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- EDSA
- Stock Information
- Founded
- AEI 2014
- EDSA 2015
- Country
- AEI United States
- EDSA Canada
- Employees
- AEI N/A
- EDSA N/A
- Industry
- AEI Building operators
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- EDSA Health Care
- Exchange
- AEI Nasdaq
- EDSA Nasdaq
- Market Cap
- AEI 13.6M
- EDSA 15.4M
- IPO Year
- AEI N/A
- EDSA N/A
- Fundamental
- Price
- AEI $1.26
- EDSA $2.37
- Analyst Decision
- AEI
- EDSA Strong Buy
- Analyst Count
- AEI 0
- EDSA 2
- Target Price
- AEI N/A
- EDSA $13.00
- AVG Volume (30 Days)
- AEI 67.9K
- EDSA 21.9K
- Earning Date
- AEI 08-26-2025
- EDSA 08-08-2025
- Dividend Yield
- AEI N/A
- EDSA N/A
- EPS Growth
- AEI N/A
- EDSA N/A
- EPS
- AEI N/A
- EDSA N/A
- Revenue
- AEI $16,069,911.00
- EDSA N/A
- Revenue This Year
- AEI N/A
- EDSA N/A
- Revenue Next Year
- AEI N/A
- EDSA N/A
- P/E Ratio
- AEI N/A
- EDSA N/A
- Revenue Growth
- AEI 74.28
- EDSA N/A
- 52 Week Low
- AEI $0.70
- EDSA $1.55
- 52 Week High
- AEI $2.61
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- AEI 53.83
- EDSA 52.38
- Support Level
- AEI $1.16
- EDSA $2.02
- Resistance Level
- AEI $1.23
- EDSA $2.28
- Average True Range (ATR)
- AEI 0.08
- EDSA 0.13
- MACD
- AEI -0.01
- EDSA -0.01
- Stochastic Oscillator
- AEI 41.18
- EDSA 59.72
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.